Caitong International Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.6K Sell
117
-315
-73% -$177K 0.01% 667
2026
Q1
$243K Buy
+432
New +$277K 0.04% 340
2025
Q4
Sell
-56
Closed -$35.8K 2106
2025
Q3
$35.8K Buy
+56
New +$34K 0.02% 429
2025
Q2
Sell
-410
Closed -$172K 2218
2025
Q1
$172K Buy
+410
New +$178K 0.13% 152

Other funds holding IDXX

Caitong International Asset Management's IDXX Position: Q2 2026 in Review

Caitong International Asset Management reduced its Idexx Laboratories (IDXX) stake by 73% in Q2 2026, selling an estimated $177K and leaving 117 shares worth $61.6K. The position accounts for 0.01% of the portfolio, ranked #667.

Caitong International Asset Management first reported a position in IDXX in Q1 2025 and has held it in 4 quarters since. The position peaked at $243K in Q1 2026. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Caitong International Asset Management held 117 shares of Idexx Laboratories worth $61.6K as of Q2 2026.
  • Caitong International Asset Management sold 315 Idexx Laboratories shares in Q2 2026, an estimated $177K.
  • Idexx Laboratories made up 0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #667 holding.
  • Caitong International Asset Management first reported a position in Idexx Laboratories in Q1 2025 and has held it in 4 quarters since.
  • Caitong International Asset Management's Idexx Laboratories position peaked at $243K in Q1 2026.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.